Brendan Hannah - 19 Aug 2024 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
CHIEF BUSINESS OFFICER AND COO
Signature
/s/ Brendan Hannah
Issuer symbol
QNCX
Transactions as of
19 Aug 2024
Net transactions value
+$24,166
Form type
4
Filing time
21 Aug 2024, 18:38:07 UTC
Previous filing
05 Jun 2024
Next filing
11 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Purchase $1,250 +2,155 +0.84% $0.5800 259,771 19 Aug 2024 Direct
transaction QNCX Common Stock Purchase $1,525 +2,500 +0.96% $0.6100 262,271 20 Aug 2024 Direct
transaction QNCX Common Stock Purchase $2,054 +3,424 +1.3% $0.6000 265,695 20 Aug 2024 Direct
transaction QNCX Common Stock Purchase $1,391 +2,280 +0.86% $0.6100 267,975 21 Aug 2024 Direct
transaction QNCX Common Stock Purchase $3,100 +5,000 +1.9% $0.6200 272,975 21 Aug 2024 Direct
transaction QNCX Common Stock Purchase $14,846 +23,565 +8.6% $0.6300 296,540 21 Aug 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.